Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo

Filing of GranuFlo lawsuits is on the rise as serious risks alleged with GranuFlo use

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

ST. LOUIS (PRWEB) October 19, 2013

The GranuFlo recall lawyers at Baron and Budd are reviewing GranuFlo claims relating to the March 2012 GranuFlo and NaturaLyte recall. Dialysis concentrates used during dialysis treatments to help clean the blood, both GranuFlo and NaturaLyte are manufactured and marketed by Fresenius Medical Care, the world's largest provider of dialysis products. Both dialysis concentrates were recalled by the Food and Drug Administration (FDA) as a Class I recall, the highest form of drug recall in the United States used only when a medical product can cause serious health conditions or even death. (http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm)

Dialysis patients or their loved ones may be eligible to file a GranuFlo lawsuit with Baron and Budd's GranuFlo recall lawyers if they suffered from a heart attack during or following a dialysis treatment. This dialysis treatment may have involved the use of GranuFlo or NaturaLyte and therefore could be the cause of the patient's injury.

At this time, Baron and Budd is continuing to review GranuFlo lawsuit claims, providing individuals who may be eligible to file a GranuFlo lawsuit claim with a free legal consultation. All consultations are confidential.

The risk of heart attack associated with the use of GranuFlo and NaturaLyte involves the increased bicarbonate associated with these particular dialysis concentrates. Both GranuFlo and NaturaLyte are more likely to cause a higher level of bicarbonate in the blood compared to other dialysis concentrates in their class. As doctors were uninformed of the increased bicarbonate associated with GranuFlo and NaturaLyte, patients were in turn put at risk for heart attacks allegedly caused by an overdose of bicarbonate. (http://www.prweb.com/releases/2013/5/prweb10700127.htm)

"The FDA does not take Class I recalls lightly. These recalls occur only when there is a reasonable probability that the product could cause serious health condition or even death," says Russell Budd of Baron and Budd. “While the Class I recall is an important step in ensuring dialysis patient safety, work needs to be done to help patients who have already been injured. Our GranuFlo lawyers are taking the necessary steps to help these injured patients by providing confidential and free consultations to patients who have suffered heart attacks following dialysis treatment."

To learn more about Baron and Budd's work on the GranuFlo lawsuit please visit the firm's website at http://baronandbudd.com/areas-of-practice/pharmaceuticals/granuflo-lawyer/

To speak with a GranuFlo lawyer as part of Baron and Budd's free and confidential GranuFlo recall consultations, please call 1.866.472.9108.

About Baron & Budd, P.C.

With a history of over 35 years “Protecting What’s Right” for individuals, communities, and governmental entities, Baron and Budd is a well-established law firm devoted to making a positive difference. With offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd is able to take on complicated and expensive cases within the realms of dangerous drugs and medical devices, asbestos-related illnesses, consumer fraud, water contamination, the Gulf oil spill and fraudulent financial practices.


Contact